505 related articles for article (PubMed ID: 19464747)
1. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
Zocco MA; Di Stasio E; De Cristofaro R; Novi M; Ainora ME; Ponziani F; Riccardi L; Lancellotti S; Santoliquido A; Flore R; Pompili M; Rapaccini GL; Tondi P; Gasbarrini GB; Landolfi R; Gasbarrini A
J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
[TBL] [Abstract][Full Text] [Related]
2. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
3. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
[TBL] [Abstract][Full Text] [Related]
5. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
[TBL] [Abstract][Full Text] [Related]
6. Portal vein thrombosis and survival in patients with cirrhosis.
Englesbe MJ; Kubus J; Muhammad W; Sonnenday CJ; Welling T; Punch JD; Lynch RJ; Marrero JA; Pelletier SJ
Liver Transpl; 2010 Jan; 16(1):83-90. PubMed ID: 20035521
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
8. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.
Stine JG; Wang J; Shah PM; Argo CK; Intagliata N; Uflacker A; Caldwell SH; Northup PG
Liver Int; 2018 Jan; 38(1):94-101. PubMed ID: 28632958
[TBL] [Abstract][Full Text] [Related]
9. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes.
Maruyama H; Okugawa H; Takahashi M; Yokosuka O
Am J Gastroenterol; 2013 Apr; 108(4):568-74. PubMed ID: 23381015
[TBL] [Abstract][Full Text] [Related]
10. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis.
Zhang DL; Hao JY; Yang N
J Int Med Res; 2013 Jun; 41(3):664-72. PubMed ID: 23637275
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into the development of portal vein thrombosis in cirrhosis patients.
Qi X; Li H; Liu X; Yao H; Han G; Hu F; Shao L; Guo X
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1421-32. PubMed ID: 26325361
[TBL] [Abstract][Full Text] [Related]
12. Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis.
Dai J; Qi X; Li H; Guo X
Saudi J Gastroenterol; 2015; 21(3):165-74. PubMed ID: 26021776
[TBL] [Abstract][Full Text] [Related]
13. Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.
Rossetto V; Spiezia L; Senzolo M; Rodriguez K; Gavasso S; Woodhams B; Simioni P
Int J Lab Hematol; 2013 Feb; 35(1):101-5. PubMed ID: 22958499
[TBL] [Abstract][Full Text] [Related]
14. The risk of thrombotic events in patients with liver cirrhosis.
Gîrleanu I; Trifan A; Cojocariu C; Sîngeap AM; Sfarti C; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):991-6. PubMed ID: 23700877
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
[TBL] [Abstract][Full Text] [Related]
16. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.
Chen H; Qi X; He C; Yin Z; Fan D; Han G
Thromb Res; 2013 Feb; 131(2):173-7. PubMed ID: 23157737
[TBL] [Abstract][Full Text] [Related]
17. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.
Amitrano L; Brancaccio V; Guardascione MA; Margaglione M; Iannaccone L; D'Andrea G; Marmo R; Ames PR; Balzano A
Hepatology; 2000 Feb; 31(2):345-8. PubMed ID: 10655256
[TBL] [Abstract][Full Text] [Related]
18. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
[TBL] [Abstract][Full Text] [Related]
19. Changing perspectives in portal vein thrombosis.
Janssen HL
Scand J Gastroenterol Suppl; 2000; (232):69-73. PubMed ID: 11232496
[TBL] [Abstract][Full Text] [Related]
20. Portal vein thrombosis: a predictable milestone in cirrhosis?
Garcia-Pagan JC; Valla DC
J Hepatol; 2009 Oct; 51(4):632-4. PubMed ID: 19660824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
